v3.25.4
Consolidated Statements of Stockholders' Equity - USD ($)
shares in Thousands, $ in Millions
Total
Common stock:
Additional paid-in capital:
Treasury stock:
Accumulated other comprehensive income:
Accumulated deficit:
Balance, beginning of period (in shares) at Jan. 31, 2023   257,991        
Balance, beginning of period at Jan. 31, 2023   $ 0 $ 8,829 $ (185) $ 53 $ (3,112)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Issuance of common stock under employee equity plans (in shares)   7,739        
Issuance of common stock under employee equity plans   $ 0 177      
Issuance of common stock in business combination (in shares)   76        
Shares withheld related to net share settlement of equity awards (in shares)   (95)        
Shares withheld related to net share settlement of equity awards   $ 0 (22)      
Share-based compensation     1,416      
Common stock repurchased (in shares)   (1,849)        
Common stock repurchases under share repurchase programs   $ (423)   (423)    
Other comprehensive income (loss) $ (32)       (32)  
Net income 1,381         1,381
Balance, end of period (in shares) at Jan. 31, 2024   263,862        
Balance, end of period at Jan. 31, 2024 8,082 $ 0 10,400 (608) 21 (1,731)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Issuance of common stock under employee equity plans (in shares)   7,959        
Issuance of common stock under employee equity plans   $ 0 186      
Issuance of common stock in business combination (in shares)   24        
Shares withheld related to net share settlement of equity awards (in shares)   (2,579)        
Shares withheld related to net share settlement of equity awards   $ 0 (649)      
Share-based compensation     1,526      
Common stock repurchased (in shares)   (2,914)        
Common stock repurchases under share repurchase programs   $ (700)   (700)    
Other comprehensive income (loss) 63       63  
Net income 526         526
Balance, end of period (in shares) at Jan. 31, 2025   266,352        
Balance, end of period at Jan. 31, 2025 9,034 $ 0 11,463 (1,308) 84 (1,205)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Issuance of common stock under employee equity plans (in shares)   7,869        
Issuance of common stock under employee equity plans   $ 0 192      
Issuance of common stock in business combination (in shares)   382        
Shares withheld related to net share settlement of equity awards (in shares)   (2,700)        
Shares withheld related to net share settlement of equity awards   $ 0 (614)      
Share-based compensation     1,632      
Common stock repurchased (in shares)   (12,772)        
Common stock repurchases under share repurchase programs   $ (2,894)   (2,912)    
Other comprehensive income (loss) (220)       (220)  
Net income 693         693
Balance, end of period (in shares) at Jan. 31, 2026   259,131        
Balance, end of period at Jan. 31, 2026 $ 7,805 $ 0 $ 12,673 $ (4,220) $ (136) $ (512)